Report cover image

Global Drug and Gene Delivery System Market Growth (Status and Outlook) 2023-2029

Publisher LP Information, Inc.
Published Jun 16, 2023
Length 121 Pages
SKU # LPI18011698

Description

Global Drug and Gene Delivery System Market Growth (Status and Outlook) 2023-2029


The global Drug and Gene Delivery System market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Drug and Gene Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Drug and Gene Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Drug and Gene Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Drug and Gene Delivery System players cover Pfizer, Johnson & Johnson, Novartis, Roche, Merck & Co., Sanofi, GlaxoSmithKline, AbbVie and AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Drug and Gene Delivery System Industry Forecast” looks at past sales and reviews total world Drug and Gene Delivery System sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug and Gene Delivery System sales for 2023 through 2029. With Drug and Gene Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug and Gene Delivery System industry.

This Insight Report provides a comprehensive analysis of the global Drug and Gene Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug and Gene Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug and Gene Delivery System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug and Gene Delivery System and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug and Gene Delivery System.

This report presents a comprehensive overview, market shares, and growth opportunities of Drug and Gene Delivery System market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Drug Delivery System
Gene Delivery System

Segmentation by application
Diabetes
Central Nervous System
Infectious Disease
Oncology
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Johnson & Johnson
Novartis
Roche
Merck & Co.
Sanofi
GlaxoSmithKline
AbbVie
AstraZeneca
Bayer
Bristol-MyersSquibb
Celgene
Amgen
Biogen
Gilead Sciences
Illumina
Regeneron Pharmaceuticals
Vertex Pharmaceuticals
Moderna
CRISPR Therapeutics

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

121 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug and Gene Delivery System Market Size 2018-2029
2.1.2 Drug and Gene Delivery System Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Drug and Gene Delivery System Segment by Type
2.2.1 Drug Delivery System
2.2.2 Gene Delivery System
2.3 Drug and Gene Delivery System Market Size by Type
2.3.1 Drug and Gene Delivery System Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Drug and Gene Delivery System Market Size Market Share by Type (2018-2023)
2.4 Drug and Gene Delivery System Segment by Application
2.4.1 Diabetes
2.4.2 Central Nervous System
2.4.3 Infectious Disease
2.4.4 Oncology
2.4.5 Other
2.5 Drug and Gene Delivery System Market Size by Application
2.5.1 Drug and Gene Delivery System Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Drug and Gene Delivery System Market Size Market Share by Application (2018-2023)
3 Drug and Gene Delivery System Market Size by Player
3.1 Drug and Gene Delivery System Market Size Market Share by Players
3.1.1 Global Drug and Gene Delivery System Revenue by Players (2018-2023)
3.1.2 Global Drug and Gene Delivery System Revenue Market Share by Players (2018-2023)
3.2 Global Drug and Gene Delivery System Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug and Gene Delivery System by Regions
4.1 Drug and Gene Delivery System Market Size by Regions (2018-2023)
4.2 Americas Drug and Gene Delivery System Market Size Growth (2018-2023)
4.3 APAC Drug and Gene Delivery System Market Size Growth (2018-2023)
4.4 Europe Drug and Gene Delivery System Market Size Growth (2018-2023)
4.5 Middle East & Africa Drug and Gene Delivery System Market Size Growth (2018-2023)
5 Americas
5.1 Americas Drug and Gene Delivery System Market Size by Country (2018-2023)
5.2 Americas Drug and Gene Delivery System Market Size by Type (2018-2023)
5.3 Americas Drug and Gene Delivery System Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug and Gene Delivery System Market Size by Region (2018-2023)
6.2 APAC Drug and Gene Delivery System Market Size by Type (2018-2023)
6.3 APAC Drug and Gene Delivery System Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug and Gene Delivery System by Country (2018-2023)
7.2 Europe Drug and Gene Delivery System Market Size by Type (2018-2023)
7.3 Europe Drug and Gene Delivery System Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug and Gene Delivery System by Region (2018-2023)
8.2 Middle East & Africa Drug and Gene Delivery System Market Size by Type (2018-2023)
8.3 Middle East & Africa Drug and Gene Delivery System Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug and Gene Delivery System Market Forecast
10.1 Global Drug and Gene Delivery System Forecast by Regions (2024-2029)
10.1.1 Global Drug and Gene Delivery System Forecast by Regions (2024-2029)
10.1.2 Americas Drug and Gene Delivery System Forecast
10.1.3 APAC Drug and Gene Delivery System Forecast
10.1.4 Europe Drug and Gene Delivery System Forecast
10.1.5 Middle East & Africa Drug and Gene Delivery System Forecast
10.2 Americas Drug and Gene Delivery System Forecast by Country (2024-2029)
10.2.1 United States Drug and Gene Delivery System Market Forecast
10.2.2 Canada Drug and Gene Delivery System Market Forecast
10.2.3 Mexico Drug and Gene Delivery System Market Forecast
10.2.4 Brazil Drug and Gene Delivery System Market Forecast
10.3 APAC Drug and Gene Delivery System Forecast by Region (2024-2029)
10.3.1 China Drug and Gene Delivery System Market Forecast
10.3.2 Japan Drug and Gene Delivery System Market Forecast
10.3.3 Korea Drug and Gene Delivery System Market Forecast
10.3.4 Southeast Asia Drug and Gene Delivery System Market Forecast
10.3.5 India Drug and Gene Delivery System Market Forecast
10.3.6 Australia Drug and Gene Delivery System Market Forecast
10.4 Europe Drug and Gene Delivery System Forecast by Country (2024-2029)
10.4.1 Germany Drug and Gene Delivery System Market Forecast
10.4.2 France Drug and Gene Delivery System Market Forecast
10.4.3 UK Drug and Gene Delivery System Market Forecast
10.4.4 Italy Drug and Gene Delivery System Market Forecast
10.4.5 Russia Drug and Gene Delivery System Market Forecast
10.5 Middle East & Africa Drug and Gene Delivery System Forecast by Region (2024-2029)
10.5.1 Egypt Drug and Gene Delivery System Market Forecast
10.5.2 South Africa Drug and Gene Delivery System Market Forecast
10.5.3 Israel Drug and Gene Delivery System Market Forecast
10.5.4 Turkey Drug and Gene Delivery System Market Forecast
10.5.5 GCC Countries Drug and Gene Delivery System Market Forecast
10.6 Global Drug and Gene Delivery System Forecast by Type (2024-2029)
10.7 Global Drug and Gene Delivery System Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Drug and Gene Delivery System Product Offered
11.1.3 Pfizer Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Drug and Gene Delivery System Product Offered
11.2.3 Johnson & Johnson Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Drug and Gene Delivery System Product Offered
11.3.3 Novartis Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche Drug and Gene Delivery System Product Offered
11.4.3 Roche Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 Merck & Co.
11.5.1 Merck & Co. Company Information
11.5.2 Merck & Co. Drug and Gene Delivery System Product Offered
11.5.3 Merck & Co. Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Merck & Co. Main Business Overview
11.5.5 Merck & Co. Latest Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi Drug and Gene Delivery System Product Offered
11.6.3 Sanofi Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Sanofi Main Business Overview
11.6.5 Sanofi Latest Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Information
11.7.2 GlaxoSmithKline Drug and Gene Delivery System Product Offered
11.7.3 GlaxoSmithKline Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 GlaxoSmithKline Main Business Overview
11.7.5 GlaxoSmithKline Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Drug and Gene Delivery System Product Offered
11.8.3 AbbVie Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Information
11.9.2 AstraZeneca Drug and Gene Delivery System Product Offered
11.9.3 AstraZeneca Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 AstraZeneca Main Business Overview
11.9.5 AstraZeneca Latest Developments
11.10 Bayer
11.10.1 Bayer Company Information
11.10.2 Bayer Drug and Gene Delivery System Product Offered
11.10.3 Bayer Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Bayer Main Business Overview
11.10.5 Bayer Latest Developments
11.11 Bristol-MyersSquibb
11.11.1 Bristol-MyersSquibb Company Information
11.11.2 Bristol-MyersSquibb Drug and Gene Delivery System Product Offered
11.11.3 Bristol-MyersSquibb Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Bristol-MyersSquibb Main Business Overview
11.11.5 Bristol-MyersSquibb Latest Developments
11.12 Celgene
11.12.1 Celgene Company Information
11.12.2 Celgene Drug and Gene Delivery System Product Offered
11.12.3 Celgene Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Celgene Main Business Overview
11.12.5 Celgene Latest Developments
11.13 Amgen
11.13.1 Amgen Company Information
11.13.2 Amgen Drug and Gene Delivery System Product Offered
11.13.3 Amgen Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Amgen Main Business Overview
11.13.5 Amgen Latest Developments
11.14 Biogen
11.14.1 Biogen Company Information
11.14.2 Biogen Drug and Gene Delivery System Product Offered
11.14.3 Biogen Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Biogen Main Business Overview
11.14.5 Biogen Latest Developments
11.15 Gilead Sciences
11.15.1 Gilead Sciences Company Information
11.15.2 Gilead Sciences Drug and Gene Delivery System Product Offered
11.15.3 Gilead Sciences Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Gilead Sciences Main Business Overview
11.15.5 Gilead Sciences Latest Developments
11.16 Illumina
11.16.1 Illumina Company Information
11.16.2 Illumina Drug and Gene Delivery System Product Offered
11.16.3 Illumina Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Illumina Main Business Overview
11.16.5 Illumina Latest Developments
11.17 Regeneron Pharmaceuticals
11.17.1 Regeneron Pharmaceuticals Company Information
11.17.2 Regeneron Pharmaceuticals Drug and Gene Delivery System Product Offered
11.17.3 Regeneron Pharmaceuticals Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Regeneron Pharmaceuticals Main Business Overview
11.17.5 Regeneron Pharmaceuticals Latest Developments
11.18 Vertex Pharmaceuticals
11.18.1 Vertex Pharmaceuticals Company Information
11.18.2 Vertex Pharmaceuticals Drug and Gene Delivery System Product Offered
11.18.3 Vertex Pharmaceuticals Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Vertex Pharmaceuticals Main Business Overview
11.18.5 Vertex Pharmaceuticals Latest Developments
11.19 Moderna
11.19.1 Moderna Company Information
11.19.2 Moderna Drug and Gene Delivery System Product Offered
11.19.3 Moderna Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Moderna Main Business Overview
11.19.5 Moderna Latest Developments
11.20 CRISPR Therapeutics
11.20.1 CRISPR Therapeutics Company Information
11.20.2 CRISPR Therapeutics Drug and Gene Delivery System Product Offered
11.20.3 CRISPR Therapeutics Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 CRISPR Therapeutics Main Business Overview
11.20.5 CRISPR Therapeutics Latest Developments
12 Research Findings and Conclusion

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us